Skip to main content

Dr Girija Anand

Consultant Clinical Oncologist

MBBS, MRCP, FRCR

Practises at: The Cavell Hospital, The Kings Oak Hospital

Dr-Girija-Anand-Oncology

Personal Profile

Dr Girija (Gij) Anand has been a Consultant in clinical oncology at North Middlesex University Hospital NHS Trust since her appointment in January 2011. 

She obtained her MRCP in 2002. Completed her higher specialist training in clinical oncology in London in 2009. She is a fellow of the Royal College of Radiologists since September 2007.

Dr Anand has wide experience in the general oncological management of various tumour sites. Her expertise is in treating tumours of the breast, and skin (non melanoma) malignancies. This includes the delivery of novel radiotherapy techniques including stereotactic radiotherapy and medical oncology.

She has an active interest in research, teaching and recruits into national and commercial clinical trials. Another key area of interest is service development in the modern NHS. Her subsequent leadership roles included:

  • Acute oncology lead 2011-2012 and member of London Cancer Acute Oncology External Reference Group 2012
  • Radiotherapy lead for London cancer skin pathway board established to streamline skin cancer pathways across north central London(2012-2017)
  • Clinical Director for oncology & palliative care at North Middlesex (2014-2018)
  • Radiotherapy Strategic lead for Royal Free London & North Middlesex University Hospitals 2018-2019
  • Faculty member for Clinical Oncology at the Royal College of Radiologists Sept 2019-2022
  • Co lead for Stereotactic Ablative Body Radiotherapy at North Middlesex University Hospital since 2019
  • Associate Medical Director, Deputy Responsible Officer and Trust Appraisal lead at North Middlesex University Hospital since March 2022

Leadership courses:

  1.  Royal Free Bohmer Leadership Course 2017
  2. Kings Fund Leadership and development Course Sept 2015- March 2016
  3. New Clinical Directors in Oncology Feb 2015
  4. KPMG management course at North Mid 2012

Awards:

  • Gold medallist in Ophthalmology MBBS India

Clinical Interests

  • Breast cancer
  • Non-melanoma skin cancer

Professional Memberships

  • Royal College of Radiologists
  • British Medical Association

Publications:

Patient information videos on SACT to improve patient experience and access to information: A North/NE London collaboration
V Kontehi, G Anand, Virginia Wolstenholme, LC Yew et al
Clinical Oncology 34:e11-e12, November 2022

Remote Consultations (RCs): a Survey of Oncology Practices and Patient Experience
A Anasova, G Anand, K Khan et al
Clinical Oncology 34(4):e177, April 2022

Enhancing patient experiences with remote/virtual consultations (RC/VCs) for a sustainable standard practice model: A Quality Improvement Project.
Obaid Syed, Anna Anosova, Kyle Kelleher, Caroline Dancyger, G Anand, K Khan et al
Journal of Clinical Oncology 40(16_suppl):e18620-e18620, June 2020

Delivery of high-dose radiation for recurrence of breast cancer in a patient with hidradenitis suppurativa
Hamoun Rozati, Felicity Ferguson, Ellie Rashidghamat, Girija Anand
BMJ Case reports, November 2020

Lung Cancer Treatment in COVID-19-Positive Patients: Guidelines and Gestalt
Aryeh Greenberg, Girija Anand, Georges Sinclair
JCO Oncology Practice; Volume 16, Issue 9, August 2020

Life Threatening Pembrolizumab Induced Myositis in a Patient Treated for Advanced Adenocarcinoma of the Lung
S Robinson C Lai G Hotton And G Anand Acute Medicine Journal, Volume 18, Issue 3, pages 137-204(2019)

Organising pneumonia during breast cancer treatment with trastuzumab
Wing-Kin Liu Rebecca Gillibrand Ian Moonsie Girija Anand Ricardo J. José Annals of Research Hospitals, August 2019

Phylogenetic ctDNA analysis depicts early stage lung cancer evolution
C Abbosh, TRACER X consortium(G Anand), C Swanton et al
Nature 545, 446-451 (25 May 2017)

Tracking the Evolution of Non Small Cell Lung Cancer
M Jamal-Hanjani, TRACER X consortium(G Anand), C Swanton et al
N England Journal of Medicine 2017, 376: 2109-2121

Several papers published as part of the Tracer X consortium; https://www.researchgate.net/scientific-contributions/Girija-Anand-2126004961

Palliative Whole Brain Radiotherapy for Cerebral Metastases in Advanced Lung Cancer: does it make a difference?
H Buckley, N Bhuva, A Ranger, N Goyal, G Anand et al European Journal of Palliative Care Vol 22.5, October 2015

Palliative Radiotherapy for Merkell Cell Carcinoma; Single centre experience and review of the literature 
B Kanagaratnam, A Shah and G Anand Journal of Radiotherapy in Practice Published online Volume 15, Issue 2, June 2016 pages 189-195

Superior vena cava stent migration into the pulmonary artery causing fatal pulmonary infarction
G Anand, C Lewanski, S Cowman and J Jackson Cardiovascular and Interventional Radiology February 2010

Neoadjuvant Docetaxel/ Platinum /Fluorouracil (TPF) chemotherapy prior to concurrent chemoradiation in locally advanced head & neck cancer: A single institution study of acute toxicity and response evaluation
O Hatcher, G Anand, R Woolfe, G Mamdani, S Partridge and S StewartEuropean Archive Otorhinolaryngology  Abstract Supplement: 4th EHNS Athens 4–6 March 2010 (Abstract and poster presentation) 
i